Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and ...

The prevalence of combined warfarin and antiplatelet therapy was 388 per 1,000 patients (95% confidence interval [CI], 372 per 1,000 to 403 per 1,000 patients) [ Table 2]. The majority of the ...

Although anticoagulation is more effective than antiplatelet therapy in atrial fibrillation, it tends to be underutilized in the elderly. A study by van Walraven et al. examines the influence of ...

Advances in cardiovascular pharmacology have significantly enhanced patient outcomes through a new wave of medications ranging from anticoagulants and antiplatelet agents to lipid-lowering drugs and ...

Combining antihypertensives with lipid-lowering medications, diuretics, or oral anticoagulants for 5 years or more was also ...

Combining antihypertensives with lipid-lowering medications, diuretics, or oral anticoagulants for 5 years or more was also associated with a reduced risk. In contrast, use of some antiplatelet ...

or oral anticoagulants for 5 years or more was also associated with a reduced risk. In contrast, use of some antiplatelet medications — also a type of blood thinners — was associated with an ...

Cookies are files saved on your phone, tablet or computer when you visit a website. We use cookies to store information about how you use the NICE website and services, such as the pages you visit.

The combination of antiplatelet and anticoagulant therapy is more effective than either treatment alone for the initial and long-term management of acute coronary syndromes in some cases.